Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Para-n-benzene - sulfoxy-n containing doai – and said benzene...
Reexamination Certificate
2011-06-21
2011-06-21
Kim, Jennifer M (Department: 1628)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Para-n-benzene - sulfoxy-n containing doai, and said benzene...
C514S166000
Reexamination Certificate
active
07964585
ABSTRACT:
A method of treating diabetic neuropathy in a subject includes administering to a subject having diabetes or at risk of diabetes a therapeutically effective amount of a pharmaceutical composition comprising at least one of sulfasalazine or a composition including 5-aminosalicyclic acid and sulfapyridine.
REFERENCES:
patent: 5007433 (1991-04-01), Hermsdorffer et al.
patent: 5405842 (1995-04-01), Silverman
patent: 5985933 (1999-11-01), Zeitlin
patent: 6271196 (2001-08-01), O'Brien
patent: 2003/0199424 (2003-10-01), Smith et al.
patent: 2005/0271661 (2005-12-01), Manivasakam et al.
patent: WO-03032969 (2003-04-01), None
Berti-Mattera Liliana
Kern Timothy S.
Case Western Reserve University
Kim Jennifer M
Tarolli, Sundheim Covell & Tummino LLP
LandOfFree
Composition and method of treating peripheral neuropathy does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Composition and method of treating peripheral neuropathy, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Composition and method of treating peripheral neuropathy will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2725770